Patents by Inventor Josef Wieser

Josef Wieser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM C OF TIGECYCLINE DIHYDROCHLORIDE AND METHODS FOR ITS PREPARATION
    Publication number: 20120022025
    Abstract: The present invention relates to crystalline form C of Tigecycline dihydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline form C of Tigecycline dihydrochloride as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form C of Tigecycline dihydrochloride in an effective amount and to the use of crystalline form C of Tigecycline dihydrochloride as an anti-infective medicament.
    Type: Application
    Filed: December 18, 2009
    Publication date: January 26, 2012
    Applicant: SANDOZ AG
    Inventors: Andreas Hotter, Josef Wieser, Arthur Pichler, Martin Decristoforo
  • CRYSTALLINE FORM OF AN ORGANIC COMPOUND
    Publication number: 20110306764
    Abstract: The present invention is directed to a crystalline form of 2-[6-[3(R)-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]-benzonitrile, a process for the preparation of said crystalline form and the use thereof in the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: December 18, 2009
    Publication date: December 15, 2011
    Applicant: SANDOZ AG
    Inventors: Johannes Ludescher, Josef Wieser, Gerhard Laus
  • Polymorphic forms of aripiprazole and method
    Patent number: 8008490
    Abstract: The present invention relates to novel polymorphic forms of aripiprazole and processes for producing them. It further relates to pharmaceutical compositions comprising the novel forms and to the use of the novel forms in the treatment of schizophrenia.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: August 30, 2011
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Hannes Lengauer, Doris Braun, Ulrich Griesser, Richard Tessadri
  • ANTIBIOTIC COMPOUNDS
    Publication number: 20110124893
    Abstract: The present invention relates to the new crystalline solid form XI of Tigecycline and a process of preparing the same. Form XI of Tigecycline is particularly suitable for the isolation of Tigecycline in the last step of the synthesis of Tigecycline. Further the present invention relates to a process of preparing amorphous Tigecycline by spray drying form XI or another crystalline form of Tigecycline.
    Type: Application
    Filed: January 19, 2009
    Publication date: May 26, 2011
    Applicant: SANDOZ AG
    Inventors: Martin Decristoforo, Josef Wieser, Arthur Pichler, Andreas Hotter
  • CRYSTALLINE FORMS OF TIGECYCLINE HYDROCHLORIDE
    Publication number: 20110105772
    Abstract: The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline forms A and B of Tigecycline hydrochloride as intermediates for the formulation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form A of Tigecycline hydrochloride in an effective amount and to the use of crystalline form A of Tigecycline hydrochloride as anti-infective medicament.
    Type: Application
    Filed: November 12, 2008
    Publication date: May 5, 2011
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Andreas Hotter, Arthur Pichler
  • PHARMACEUTICAL COMPOSITIONS CONTAINING A CRYSTALLINE FORM OF POSACONAZOLE
    Publication number: 20110105525
    Abstract: The present invention relates to a pharmaceutical composition comprising crystalline form Y of posaconazole. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Application
    Filed: May 28, 2009
    Publication date: May 5, 2011
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes, Christian Laschober
  • A CRYSTALLINE FORM OF POSACONAZOLE
    Publication number: 20110065722
    Abstract: The present invention relates to crystalline form IV of posaconazole and pharmaceutical compositions comprising the same. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Application
    Filed: June 25, 2009
    Publication date: March 17, 2011
    Applicant: Sandoz AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes
  • ORGANIC COMPOUNDS
    Publication number: 20110015191
    Abstract: Novel polymorph form III of Aprepitant and a method for preparation of novel form III is disclosed. New processes for the preparation of Aprepitant form II are disclosed. The processes involve transformation of form III to form II by heating in decalin and the precipitation of form II from a solvent or solvent mixture by cooling and/or addition of addition of seed crystals or an anti solvent. Solid dispersions containing Aprepitant form II in a suitable carrier are disclosed. A process for the preparation of the solid dispersion by evaporation of a solution of Aprepitant and the carrier in a suitable solvent is disclosed. Stable Aprepitant form II is disclosed. Further pharmaceutical compositions containing Aprepitant form II, III or solid dispersions containing Aprepitant form II in a suitable carrier are disclosed. A methanol solvate of Aprepitant is disclosed.
    Type: Application
    Filed: February 22, 2008
    Publication date: January 20, 2011
    Applicant: SANDOZ AG
    Inventors: Johannes Ludescher, Josef Wieser, Arthur Pichler, Ulrich Griesser, Doris Braun
  • NOVEL SOLVATE
    Publication number: 20100256402
    Abstract: The present invention relates to the novel crystalline form X of Tigecycline and to processes of preparing the same. Furthermore the present invention relates to the use of crystalline form X of Tigecycline as an intermediate for the preparation of an anti-infective medicament.
    Type: Application
    Filed: November 12, 2008
    Publication date: October 7, 2010
    Applicant: Sandoz AG
    Inventors: Andreas Hotter, Josef Wieser, Arthur Pichler
  • METHOD FOR SALT PREPARATION
    Publication number: 20100204470
    Abstract: The present invention provides a new method for preparation and crystallization of hydrochlorides, hydrobromides or hydroiodides of pharmaceutical compounds or their intermediates in which the base or its acid addition salt is reacted in a solvent with a Trialkylsilylhalogenide.
    Type: Application
    Filed: June 25, 2007
    Publication date: August 12, 2010
    Inventors: Josef Wieser, Hannes Lengauer, Elfriede Klingler, Arthur Pichler, Hubert Sturm
  • CRYSTALLINE SOLID FORMS
    Publication number: 20100160264
    Abstract: The present invention relates to the new crystalline solid form VI and VIII of tigecycline and processes for the production of form VI and VIII. It further relates to a new method for preparing Form I and Form III in high polymorphic purity.
    Type: Application
    Filed: June 20, 2008
    Publication date: June 24, 2010
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter
  • AMORPHOUS FORM OF CINACALCET
    Publication number: 20090258949
    Abstract: The present invention relates to dispersions of stable amorphous cinacalcet hydrochloride in a matrix material, methods for the preparation thereof, and pharmaceutical compositions comprising said dispersions.
    Type: Application
    Filed: June 25, 2007
    Publication date: October 15, 2009
    Inventors: Johannes Ludescher, Ulrich Griesser, Doris Braun, Josef Wieser
  • CRYSTALLINE FORM OF CINACALCET
    Publication number: 20090197970
    Abstract: The present invention relates to the polymorph form II of Cinacalcet hydrochloride, methods for the preparation of pure form II of Cinacalcet hydrochloride, and pharmaceutical compositions comprising the new polymorphic form in an pharmaceutically effective amount The present invention also provides novel solvates of Cinacalcet hydrochloride, methods for the preparation of these solvates, the use of these novel solvates for the preparation of pure Cinacalcet hydrochloride, the use of these novel solvates for the preparation of polymorphic form II of Cinacalcet hydrochloride and pharmaceutical compositions comprising the acetic acid solvate of Cinacalcet hydrochloride.
    Type: Application
    Filed: June 25, 2007
    Publication date: August 6, 2009
    Inventors: Johannes Ludescher, Ulrich Griesser, Doris Braun, Josef Wieser
  • Cephalosporins
    Patent number: 7485632
    Abstract: A compound of formula wherein the substituents have various meanings, useful as a pharmaceutical.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: February 3, 2009
    Assignee: Nabriva Therapeutics Forschungs GmbH
    Inventors: Gerd Ascher, Werner Heilmayer, Michael Schranz, Josef Wieser
  • Organic Compounds
    Publication number: 20080132518
    Abstract: The present invention relates to novel polymorphic forms of aripiprazole and processes for producing them. It further relates to pharmaceutical compositions comprising the novel forms and to the use of the novel forms in the treatment of schizophrenia.
    Type: Application
    Filed: January 27, 2006
    Publication date: June 5, 2008
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Hannes Lengauer, Doris Braun, Ulrich Griesser, Richard Tessadri
  • Process for preparing polymorphic form II of sertraline hydrochloride
    Patent number: 7253320
    Abstract: The present invention relates to a new process for preparing sertraline hydrochloride form II.
    Type: Grant
    Filed: April 3, 2006
    Date of Patent: August 7, 2007
    Assignee: Sandoz AG
    Inventors: Johannes Ludescher, Josef Wieser
  • Process for preparing polymorphic form II of sertraline hydrochloride
    Publication number: 20060229472
    Abstract: The present invention relates to a new process for preparing sertraline hydrochloride form II.
    Type: Application
    Filed: April 3, 2006
    Publication date: October 12, 2006
    Inventors: Johannes Ludescher, Josef Wieser
  • Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
    Publication number: 20060223789
    Abstract: A compound of formula wherein W, V, R1, R5, R2, R3 and R4 have various meanings, a process for their production and their use as a pharmaceutical.
    Type: Application
    Filed: December 5, 2005
    Publication date: October 5, 2006
    Inventors: Gerd Ascher, Josef Wieser, Michael Schranz, Jonannes Ludescher, Johannes Hilldebrandt
  • Cephalosporins
    Publication number: 20050234233
    Abstract: A compound of formula wherein the substituents have various meanings, useful as a pharmaceutical.
    Type: Application
    Filed: July 14, 2003
    Publication date: October 20, 2005
    Inventors: Gerd Ascher, Werner Heilmayer, Michael Schranz, Josef Wieser
  • Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
    Publication number: 20040132709
    Abstract: A compound of formula 1
    Type: Application
    Filed: November 12, 2003
    Publication date: July 8, 2004
    Inventors: Gerd Ascher, Josef Wieser, Michael Schranz, Johannes Ludescher, Johannes Hildebrandt